You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

molecular remission

Showing 1 - 25 of 8,221
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dissecting Cellular and Molecular Atlas of Rheumatoid Arthritis

Recruiting
  • Rheumatoid Arthritis
  • Tapering and/or discontinuation of treatment based on AI-guidance
  • +3 more
  • Rome, Italy
  • +3 more
Jul 20, 2023

CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

Recruiting
  • CML
  • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
  • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
    FUNDALEU
Jun 29, 2023

3TR Asthma Biologics Cohort (ABC) Study

Recruiting
  • Severe Asthma
    • Copenhagen, Denmark
    • +1 more
    Nov 6, 2023

    Crohn's Disease, Ulcerative Colitis Trial (Samples)

    Not yet recruiting
    • Crohn's Disease
    • Ulcerative Colitis
    • Samples
    • (no location specified)
    Feb 8, 2023

    Chronic Myeloid Leukemia, Chronic Phase, Withdrawal;Drug Trial in Czechia (Imatinib withdrawal, Dasatinib, Nilotinib)

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Withdrawal;Drug
    • Imatinib withdrawal
    • +2 more
    • Brno, Czechia
    • +7 more
    Aug 24, 2022

    Chronic Leukemia Trial in France (Additional biological samples)

    Active, not recruiting
    • Chronic Leukemia
    • Additional biological samples
    • Besançon, France
    • +3 more
    May 31, 2022

    Leukemia, Chronic Myeloid Trial in Ann Arbor, Winston-Salem (Nilotinib, Ruxolitinib)

    Withdrawn
    • Leukemia, Chronic Myeloid
    • Ann Arbor, Michigan
    • +1 more
    Feb 11, 2021

    AML Patients After Stem Cell Transplant to Understand Relapse

    Recruiting
    • Acute Myeloid Leukemia in Remission
    • Prospective determination of the clinical utility of measurable residual disease (MRD) testing
    • Duarte, California
    • +3 more
    Dec 7, 2022

    Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission, Chronic Myeloid Leukemia in Remission Trial

    Recruiting
    • Chronic Myeloid Leukemia
    • +2 more
    • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Withdrawal
    • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Re-initiation
    • Houston, Texas
    • +3 more
    Jan 25, 2022

    Refractory B-cell Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia Trial in Worldwide (UCART19)

    Completed
    • Refractory B-cell Acute Lymphoblastic Leukemia
    • Relapsed B-cell Acute Lymphoblastic Leukemia
    • UCART19
    • Los Angeles, California
    • +5 more
    Sep 30, 2021

    Chronic Myeloid Leukemia Trial in Germany, Netherlands (TKI discontinuation, nilotinib)

    Active, not recruiting
    • Chronic Myeloid Leukemia
    • Freiburg, Baden-Württemberg, Germany
    • +14 more
    Nov 4, 2021

    Leukemia, Chronic Myeloid Trial in Campinas (Pioglitazone, imatinib discontinuation)

    Active, not recruiting
    • Leukemia, Chronic Myeloid
    • Campinas, SP, Brazil
      Centro de Hematologia e Hemoterapia - Universidade Estadual de C
    Nov 2, 2020

    Complete Molecular Remission After Stopping Imatinib Chronic

    Completed
    • Chronic Myeloid Leukemia
    • Interruption of the treatment by Imatinib
    • Angers, France
    • +18 more
    Jun 18, 2020

    Chronic Myeloid Leukemia Trial in Worldwide (Stopping treatment with TKI)

    Completed
    • Chronic Myeloid Leukemia
    • Stopping treatment with TKI
    • Brno, Czechia
    • +49 more
    Oct 29, 2021

    Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Worldwide (procedure, other, drug)

    Recruiting
    • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • Biospecimen Collection
    • +4 more
    • Birmingham, Alabama
    • +170 more
    Jan 30, 2023

    B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)

    Recruiting
    • B-Cell Lymphoblastic Leukemia
    • Acute Lymphoblastic Leukemia
    • Tampa, Florida
      Moffitt Cancer Center
    Nov 28, 2023

    Chronic Myeloid Leukemia, Chronic Myeloid Leukemia in Remission, BCR-ABL Positive Chronic Myelogenous Leukemia Trial in Moscow

    Active, not recruiting
    • Chronic Myeloid Leukemia
    • +2 more
    • Moscow, Russian Federation
      National Research Center for Hematology
    Oct 1, 2020

    Chronic Myeloid Leukemia, Treatment Free Remission Trial in Pune (Stopping the standard drug therpy, Quantitative bcrabl

    Unknown status
    • Chronic Myeloid Leukemia
    • Treatment Free Remission
    • Stopping the standard drug therpy
    • Quantitative bcrabl recording every month for first 6 months
    • Pune, Maharashtra, India
      Command Hospital
    Jul 22, 2019

    Treatment Free Remission (TFR) in CML Patients (CML-CP)Study

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Treatment-free Remission
    • TFR(Treatment-Free Remission)
    • (no location specified)
    Jun 27, 2022

    Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, ph+ Acute Lymphoblastic Leukemia Trial in Chicago (Inotuzumab ozogamicin,

    Recruiting
    • Lymphoblastic Leukemia
    • +2 more
    • Inotuzumab ozogamicin
    • +7 more
    • Chicago, Illinois
      University of Chicago Medical Center
    May 16, 2022

    TKI Discontinuation in CML Patients of China

    Recruiting
    • Leukemia
    • +4 more
      • Shenzhen, Guangdong, China
        Shenzhen Second People's Hospital
      Mar 15, 2022

      Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Trial in Frankfurt (Imatinib, Ponatinib, Blinatumomab)

      Recruiting
      • Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
      • Frankfurt, Germany
        Department of Medicine, Hematology and Oncology, Goethe Universi
      Sep 24, 2023

      Eosinophilic Myeloid Tumor, Hypereosinophilic Syndrome Trial run by the National Institute of Allergy and Infectious Diseases

      Recruiting
      • Eosinophilic Myeloid Neoplasm
      • Hypereosinophilic Syndrome
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 25, 2023

      Philadelphia-Positive ALL Trial in Suzhou (Olverembatinib)

      Not yet recruiting
      • Philadelphia-Positive ALL
      • Suzhou, Jiangsu, China
        First Affiliated Hospital of Soochow University
      Jul 1, 2023

      Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

      Not yet recruiting
      • Myelofibrosis (PMF)
      • +2 more
      • New York, New York
        Ruttenberg Treatment Center
      Apr 18, 2023